Trials / Conditions / Unresected Stage IIIb to IVM1c Melanoma
Unresected Stage IIIb to IVM1c Melanoma
3 registered clinical trials studyying Unresected Stage IIIb to IVM1c Melanoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanom NCT02366195 | Amgen | Phase 2 |
| No Longer Available | Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c M NCT02297529 | Amgen | — |
| No Longer Available | Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanom NCT02147951 | Amgen | — |